經導管二尖瓣移植術(TMVI)市場:各市場區隔規模，佔有率，法律規章，給付，手術，2033年前的預測

經導管二尖瓣植入術（TMVI）用於治療主動脈瘤和夾層。主動脈瘤可發生在胸主動脈（胸主動脈瘤 - TAA）和腹主動脈（腹主動脈瘤 - AAA）。當主動脈壁變弱並凸出時，就會發生主動脈瘤。

本報告提供全球經導管二尖瓣移植術(TMVI)市場相關詳細考察，提供市場上競爭情形，SWOT分析，到2033年前的市場預測，地區，各國的趨勢等資訊。

目錄

現在上市的經導管二尖瓣移植術(TMVI)和競爭情形

• 主要的產業趨勢的洞察
• 經導管二尖瓣移植術(TMVI)的各市場區隔整體市場收益和2015年～2033年的市場展望
• 各市場區隔的手藝總數，台數，平均銷售價格，市場價值相關詳細資料

世界，地區，各國洞察

• 經導管二尖瓣移植術(TMVI)市場SWOT分析
• 經導管二尖瓣移植術(TMVI)市場相關競爭動態的洞察和趨勢
• 各國醫療制度概要
• 各國償付政策
• 各國醫療技術相關法規狀況

Transcatheter Mitral Valve Implantation (TMVI) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.

Transcatheter Mitral Valve Implantation (TMVI) are used to treat aortic aneurysms and dissections. Aortic aneurysms can occur in both the thoracic aorta (Thoracic Aortic Aneurysms - TAA) and abdominal aorta (Abdominal Aortic Aneurysms - AAA). Aortic aneurysms occur when the walls of the aorta weaken, resulting in a large swelling and weakening of the aortic wall.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Transcatheter Mitral Valve Implantation (TMVI) market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Transcatheter Mitral Valve Implantation (TMVI) market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Transcatheter Mitral Valve Implantation (TMVI) market.
• Competitive dynamics insights and trends provided Transcatheter Mitral Valve Implantation (TMVI) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Transcatheter Mitral Valve Implantation (TMVI) marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Transcatheter Mitral Valve Implantation (TMVI) market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Mitral Valve Implantation (TMVI) market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Transcatheter Mitral Valve Implantation (TMVI) market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.